/Investor DB

Legend Capital — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

ClinChoiceclinchoice.comin𝕏Jul 2022 · $150M

ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.

BiotechHealthtechMedical DevicesPhiladelphia, US

Dr. John Balian(CEO)

PartnerFrank Hong· solo GP

Co-investorsDFJ DragonFundDraper AssociatesDraper DragonApricot CapitalLilly Asia VenturesSherpa Healthcare Partners

Eswineswin.comJan 2022 · $283M

Eswin manufactures 12-inch electronic-grade silicon wafers and epitaxial wafers for semiconductors used in storage chips, logic chips, image sensors, display driver chips, and power devices in communications and electric vehicle applications.

Advanced ManufacturingAI & Machine LearningHardwareIoTNew MaterialsSemiconductorsBeijing, CN

Wang Dongsheng(Chairman)

PartnerFrank Hong· solo GP

Co-investorsAddor CapitalSource Code CapitalChina Internet Investment FundIDG CapitalShang Qi Capital

Spectrumedicsspectrumedics.comMay 2022

Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter.

HardwareHealthtechMedical DevicesShanghai, CN

Co-investorsB Capital GroupB4 Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Legend Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.